by Jordana Choucair | Feb 2, 2022 | Opioid/Substance Use Disorders
The Department of Justice secured more than $5 billion related to fraud and false claims in the health care sector in the year ending in September 2021, making up nearly 90 percent of the agency’s settlement proceeds for False Claims Act violations. The largest...
by Jordana Choucair | Feb 2, 2022 | Opioid/Substance Use Disorders
A group of 574 Native American tribes reached a tentative $590 million settlement with Johnson & Johnson and the country’s three largest drug distributors — McKesson Corp., Cardinal Health Inc., and AmerisourceBergen Corp. — over their role in the opioid...
by Jordana Choucair | Feb 2, 2022 | Providers
Magellan Health announced that its pharmacy benefits management division plans to roll out drone delivery for some members’ medications later this year. The managed-care company, which was acquired by Centene last month, has partnered with Zipline, a company...
by Jordana Choucair | Feb 1, 2022 | Opioid/Substance Use Disorders
Adolescents and young adults lost an estimated 1.2 million years of life due to unintentional drug overdoses over between 2015 and 2019, according to a research letter published in JAMA. About 3,300 adolescents ages 10–19 years old died of an unintentional drug...
by Jordana Choucair | Feb 1, 2022 | D.C. News
President Joe Biden is set to relaunch the “cancer moonshot” program, which focused on ending cancer through investments in research and treatment, on Wednesday. Biden led the program in the final year of the Obama administration and then, in 2017,...
Recent Comments